Using Phase II Data for the Analysis of Phase III Studies: An Application in Rare Diseases

Clinical Trials - United Kingdom
doi 10.1177/1740774517699409
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

The Role of Technology in Reducing Health Care Costs. Phase II and Phase III.

2004English

Phase II Trial of CoQ10 for ALS Finds Insufficient Evidence to Justify Phase III

Annals of Neurology
Neurology
2009English

Phase III Data for Abiraterone in an Evolving Landscape for Castration-Resistant Prostate Cancer

Maturitas
BiochemistryGynecologyGeneticsObstetricsMolecular Biology
2011English

Population Pharmacokinetic Analysis of OPC-18790 Using the Data of Early Clinical Phase II Test.

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1997English

Studies on the Mechanism of Phagocytosis Ii. Analysis of the Adhesion Phase

Japanese Journal of Medical Science and Biology
1974English

Transactivation of Genes Encoding for Phase II Enzymes and Phase III Transporters by Phytochemical Antioxidants

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2010English

Safety of an Oral Fixed Combination of Netupitant and Palonosetron (NEPA): Pooled Data From the Phase II/III Clinical Program

Oncologist
Cancer ResearchMedicineOncology
2016English

Novel Therapies in Phase II and III Trials for Malignant Pleural Mesothelioma

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2012English

Phase III :

2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy